Mammoth I-Drive
Natural health product licensed in Canada
- Licence holder
- iNutrition Inc.
- NPN or DIN-HM
- 80070365
- Status
- Active licence
- Licence date
- 15 June 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycine max Source : Graine(s) Extraction ratio : 10:1 Dry plant equivalent : 1,500 milligramme | 150 milligramme | Not calculated |
| Acide (±)-1,2-dithiolane-3-pentanoïque Source : Acide DL-alpha-lipoÏque | 100 milligramme | Not calculated |
| Cinnamomum verum Source : Écorce (branche) | 25 milligramme | Not calculated |
| Chrome Source : Nicotinate de chrome (III) | 250 microgrammes | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Extraction ratio : 4:1 Dry plant equivalent : 900 milligramme | 225 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hypromellose, Phosphate dicalcique, farine de riz, Dioxyde de titane, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Provides support for health glucose metabolism. Helps the body to metabolize carbohydrates and fats. Fenugreek is traditionally used in Herbal Medicine to help stimulate the appetite, as a digestive tonic to aid digestion, as a nutritive tonic, and as supportive therapy for the promotion of healthy glucose levels. Used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidemia. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If pregnant, do not use this product.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are nursing/breastfeeding, if symptoms persist or worsen, or if you have diabetes.
Source
Official Health Canada record, licence 80070365
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.